Overview

Therapeutic Issues for Autism

Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study aimed to show the effects of hyperbaric oxygen therapy and/or Risperidone in improving symptoms of autism
Phase:
Phase 2
Details
Lead Sponsor:
Minia University
Treatments:
Risperidone